Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 24.43M P/E - EPS this Y 44.20% Ern Qtrly Grth -
Income -16.03M Forward P/E -1.54 EPS next Y 78.20% 50D Avg Chg -26.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -39.00%
Dividend N/A Price/Book 0.46 EPS next 5Y - 52W High Chg -61.00%
Recommedations 2.00 Quick Ratio 1.14 Shares Outstanding 1.57M 52W Low Chg 6.00%
Insider Own 3.02% ROA -29.25% Shares Float 240.49M Beta 0.41
Inst Own 5.48% ROE -44.67% Shares Shorted/Prior 19.69K/16.30K Price 1.08
Gross Margin - Profit Margin - Avg. Volume 77,466 Target Price 126.50
Oper. Margin - Earnings Date Nov 19 Volume 79,617 Change -2.70%
About Purple Biotech Ltd.

Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that blocks the interactions of carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 2 clinical trial for the treatment of pancreatic ductal adenocarcinoma; NT219, a small molecule that targets and inhibits insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 1/2 clinical trials for the treatment recurrent and/or metastatic squamous cell carcinoma of the head and neck cancer or colorectal adenocarcinoma; and IM1240, a multi-valent antibody designed to activate anti-tumoral immune response against 5T4-positive tumors, which is in preclinical stage. The company has collaboration agreement with Bristol Myers Squibb Company to evaluate the combination of CM24 with the PD-1 inhibitor nivolumab in addition to chemotherapy. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. The company is headquartered in Rehovot, Israel.

Purple Biotech Ltd. News
12/05/24 Purple Biotech Announces Closing of $2.8 Million Registered Direct Offering of American Depositary Shares
12/03/24 Purple Biotech Announces $2.8 Million Registered Direct Offering of American Depositary Shares
12/02/24 Purple Biotech Reports Positive Final Results from Randomized Phase 2 Study of CM24 in Second Line Pancreatic Cancer
11/15/24 Purple Biotech Reports Third Quarter 2024 Financial Results
11/05/24 Purple Biotech Unveils Promising Biomarker for Cancer Therapy
11/04/24 Purple Biotech Identifies Potential New Serum Biomarker for its Lead Oncology Therapeutic Candidate CM24: Associated with 79% Reduction in Risk of Death
10/25/24 Purple Biotech Presents New Data for its Novel Tri-Specific T Cell and NK Cell Engagers Antibody Platform, CAPTN-3, at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
10/11/24 Purple Biotech Unveils CAPTN-3 Cancer Therapy
10/10/24 Purple Biotech to Present Data for its Tri-Specific Antibody Platform—CAPTN-3—at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
09/18/24 Purple Biotech Reports Additional Positive Interim Data from its Randomized Phase 2 Study with its Lead Oncology Therapeutic Candidate CM24
09/16/24 Upcoming Stock Splits This Week (September 16 to September 20) – Stay Invested
09/10/24 Purple Biotech to Present Data for its Lead Oncology Drug CM24 at the AACR Special Conference on Advances in Pancreatic Cancer Research
08/30/24 Purple Biotech to Participate at H.C. Wainwright 26th Annual Global Investment Conference
08/16/24 Purple Biotech Reports Second Quarter 2024 Financial Results and Business Highlights
07/25/24 Purple Biotech Receives Extension to Regain Compliance with the Nasdaq’s Minimum Bid Price Rule
07/10/24 Purple Biotech to Host Virtual KOL Event to Discuss Positive Interim Results from Phase 2 Pancreatic Cancer Study with CM24 on July 11, 2024
07/02/24 Purple Biotech Announces Closing of Exercise of Warrants for $2 Million Gross Proceeds
07/01/24 Purple Biotech Announces Exercise of Warrants for $2 Million Gross Proceeds
06/27/24 Purple Biotech Reports Additional Positive Interim Results from its Randomized Phase 2 Pancreatic Cancer Study with CM24 Regarding a Potential Predictive Biomarker for Overall Survival Benefit
06/01/24 Purple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2 Data at ASCO 2024 Demonstrating CM24 Improved Overall Survival and other Efficacy Endpoints in Pancreatic Cancer
PPBT Chatroom

User Image Stocksavior14 Posted - 9 hours ago

$PPBT for limitlesstocks, price is worth $0.17 pre split price, or $0.017 pre both splits….aren’t you permabulls glad you kept managements goals aligned with our with those bonuses🤣 And to the permabulls, that’s what they would call super mega ultra bullish 🤣

User Image Stocksavior14 Posted - 9 hours ago

$PPBT weird I didn’t see you say the same thing to Covence (who also posted)…. Oh that’s right…. Only negative people you say anything about🤣🤣 4 years, 3 crashes, 2 reverse splits, multiple dilutions each year, less and less employees, still running out of money, and no NT219 partner and yet you permabulls STILL live in delusion land and unable to acknowledge that the bearish people were right 🤦🏼‍♂️🤣

User Image sonicstriker Posted - 11 hours ago

$KPTI $PPBT $SYRS

User Image JuggernautRaider Posted - 13 hours ago

$PPBT should buy $SYRS pancreatic assets and hire their US employees while they’re dirt cheap. SELECT-MDS-1 showed a 5% ORR benefit but did not show statistical significance, so it may still work for a subset of RAR-alpha high-risk MDS or AML patients. Nice post by @Covence ✅ Plus the TYME pancreatic asset fits nicely with $PPBT ‘s pancreatic cancer portfolio ambitions. ♋️ I own 1.1% of $PPBT and nothing of $SYRS currently. This just makes too much sense. I have followed Syros for years since my $KPTI days, @NoorAlTrades 👍

User Image Limitlesstocks Posted - 15 hours ago

$PPBT hey buddy cocksavior markets are closed today 😂

User Image allgoodstill Posted - 15 hours ago

$PPBT I can name a 100 events in the past 5 years that pumpers used to call this “sold”🙄. Stop it already!

User Image Stocksavior14 Posted - 20 hours ago

$PPBT. How many reverse splits are needed for people here to realize something is wrong? For example, do people need to go from 10,000 shares to 1 share worth $4 to finally say something isn’t right? CAUSE RIGHT NOW, it’s already been 10,000 shares have become 50 shares worth under $200

User Image Stocksavior14 Posted - 20 hours ago

$PPBT the problem is the asset acquisitions they made are all even less developed than our current drugs. Which means they will take WAY longer. The next problem is that you said Strategic fundraising, partnerships, asset sales…. -They still don’t have a partner for NT219 -what asset sales? No one is lining up to buy and the only asset we DID have that made anything was SHELVED (not sold) -fundraising is what they have been doing for 4 years with MULTIPLE and constant dilutions Every year. And look what that has done, left us still near broke and needing to dilute over and over and reverse split. Not so strategic then, right?

User Image JuggernautRaider Posted - 22 hours ago

$AQMS $DFLI $JFBR $PPBT $SUNE @dtocktwits or @Stocktwits needs a feature to correct typos in their posts. Right, @StocktwitsIndia ? How about @Stocksavior14 or @Stocksavior14_Cocksucker ? What does @getjiggy AKA @getjiggywithit think?

User Image Covence Posted - 1 day ago

Purple Biotech ($PPBT) is making bold moves with acquisitions like Immunorizon and looking for further asset acquisitions, even with tight cash reserves. It's a high-stakes game—balancing the need for groundbreaking innovation with funding challenges. Potential rewards could be game-changing, but the financial tightrope they're walking is precarious. Managing this risk involves strategic fundraising, partnerships, and asset sales. Let's see if they can keep the lights on and push their promising therapies through the expensive clinical trial phases. High risk, high reward!

User Image Keepitmoving Posted - 1 day ago

$PPBT You deserve to lose money you fool. That’s what keeps them going, diluting the idiots that keep propping them up. Junk

User Image JuggernautRaider Posted - 1 day ago

I’m prepare to sue @Fortune_And_Glory . @Aquameter knows $AQMS is a winner. $DFLI , $JFBR , $PPBT , and $SUNE too. 💰

User Image Stocksavior14 Posted - 1 day ago

$PPBT bulls another day of winning?🤦🏼‍♂️🤣🎉

User Image PrimeTime219 Posted - 1 day ago

$PPBT how many people got to die Izzy? think about that shit man.. that gonna be locked into your soul.

User Image Stocksavior14 Posted - 1 day ago

$PPBT he still has time, but long term shareholders don’t. 2 reverse splits have already decimated most. And most may not even see break even prices

User Image Purplepayday Posted - 1 day ago

$PPBT 911 was flashing on the ask just before closing…… just so you know…

User Image PrimeTime219 Posted - 1 day ago

$PPBT pick the right side Izzy you still have time man… i believe in you

User Image ThisWi11hurt Posted - 1 day ago

$NUWE still on schedule. It did end up going to almost 30 now which is fine, but could still dump a little more, tbh not that worried about price. Still loading this one DCA with profits. January 1st, Medicare reimbursement ups 4x. Good revenue source for outpatient clinics (dialysis, etc). $TPST $PPBT

User Image Stocksavior14 Posted - 1 day ago

$PPBT why don’t you just write them a check and use it as a donation tax write off? At least the loss is beneficial at that point lol

User Image Codeym96 Posted - 1 day ago

$PPBT let's try this again... get ready for it to drop, i just bought 1000 more shares

User Image Stocksavior14 Posted - 1 day ago

$PPBT when they run out of money again, they are going to need to delay until they can orchestrate another pump and dump DILUTION

User Image Smittysixty Posted - 1 day ago

$PPBT +500 more Average keeps getting better and better. Market cap = $9M True Value = Billions

User Image PrimeTime219 Posted - 1 day ago

$PPBT you better not shelf this shit man

User Image Dr_HIM Posted - 1 day ago

$PPBT Wash cycle just never stops 😡🤦🏽‍♂️

User Image ThisWi11hurt Posted - 1 day ago

$MYSZ Haha another one for the photo album 😘👌🏽 $tnxp $ppbt

User Image Stocksavior14 Posted - 1 day ago

$PPBT SMITTY is insane!!! He just listed everything that a SMART person with a brain would see as MAJOR issues and red flags, and somehow in his head it all adds up to something BULLISH and that somehow we are worth Billions… I like how he also left out 3 crashes and 2 reverse splits which have DESTROYED long time shareholders. Maybe even beyond repair.🤦🏼‍♂️🤦🏼‍♂️ theres some neurons in his head that aren’t working properly🤦🏼‍♂️

User Image Stocksavior14 Posted - 1 day ago

$INM $PPBT $TLSA $TNXP can you show us your position on PPBT?

User Image paulifla Posted - 1 day ago

$PPBT https://www.msn.com/en-us/money/markets/purple-biotech-stock-hits-nearly-2-month-high-on-cancer-drug-trial-success-retail-thrilled/ar-AA1v85uO?apiversion=v2&noservercache=1&domshim=1&renderwebcomponents=1&wcseo=1&batchservertelemetry=1&noservertelemetry=1 ”Retail is thrilled” Silly bot using us for a news source.

User Image jiggywithit Posted - 1 day ago

$FNF $SUNE $TNXP $PPBT $JFBR need 25k loss to sue.

User Image JuggernautRaider Posted - 1 day ago

Sorry @NewbieOneKenobi . I only have 28K shares of $TNXP - so about $16K in my IRAs. I tried to buy more last week but $FNF jobbed me yet again (I will be suing them for their selling of $JFBR and $SUNE shares in violation of SEC rules). 😤 @Investingcom also filed a fake news report about my selling of $JFBR . They need to fix it - their false reporting may have hurt its valuation- and I will battle them in an American court. 🇺🇸 I may still buy more $TNXP . Like $PPBT (@PurpleBiotech ), it is DIRT CHEAP if it gets an approval for reducing @pain for fibromyalgia patients without opioids. 🚀

Analyst Ratings
HC Wainwright & Co. Buy Aug 19, 24
HC Wainwright & Co. Buy Jul 11, 24
HC Wainwright & Co. Buy May 21, 24
HC Wainwright & Co. Buy Apr 26, 24
Chardan Capital Buy Mar 7, 24
HC Wainwright & Co. Buy Mar 5, 24
HC Wainwright & Co. Buy Feb 27, 24
HC Wainwright & Co. Buy Nov 21, 23
HC Wainwright & Co. Buy Aug 31, 23